Siden indlæses

blog.fallback_notice_title
blog.fallback_notice_body
blog.tldr_label
Fake, diluted, or improperly stored Botox often reveals itself through pricing, packaging, cold-chain errors, and unsafe clinic behavior before the needle even touches the skin.
blog.key_takeaways
When a patient tells me that a previous Botox treatment "did nothing," I do not assume the product was fake. But I do investigate the clinic, the vial, the dilution, and the storage conditions very carefully.
In real practice, suspicious Botox usually gives warning signs before the injection. The safest strategy is not to chase the cheapest price, but to verify the clinic, the product, and the injector step by step.
A price that is dramatically below market range, no medical consultation, and no explanation of dose are all immediate warning signs. If the injector refuses to show the vial or opens no box in front of you, stop the visit.
Authentic products should have a traceable batch, expiry date, and a storage history that makes sense. A legitimate medical clinic should also be able to explain who is injecting you and with which licensed product.
Botulinum toxin is a biologic product. If cold-chain handling is broken, the treatment can become weak or unreliable even when the label looks legitimate.
This is why I advise patients to ask about storage conditions, official sourcing, and written post-treatment documentation. A real clinic should not become defensive when a patient asks these questions.
Dr. Hamza Gemici: The most expensive complication is not paying more for original Botox. It is paying less for a suspicious product and then paying again to correct the result.
A weak effect alone does not prove counterfeit product, because dilution and anatomy also matter. However, no visible response by day 14, unusual side effects, or a clinic that refuses follow-up should raise concern.
If the story still does not make sense, ask for a second medical opinion. The review should include the brand, units, dilution protocol, storage, and the injector’s credentials.
U.S. Food and Drug Administration · regulator · 16. apr. 2024
DailyMed / FDA label · drug label · 18. okt. 2024
No. Low dose, excessive dilution, poor muscle targeting, and storage issues can also lead to a weak result.
Yes. In a proper medical setting, the vial, brand, and treatment plan should be transparent.
Most Botox outcomes should be assessed around day 14, when the full effect is usually visible.

Trusted & Professional
Dr. Hamza Gemici is a medical aesthetic physician based in Ataşehir, Istanbul. His practice focuses on natural anti-aging and subtle facial harmonization using botulinum toxin, dermal fillers, periocular rejuvenation and skin quality procedures. All treatments are performed with FDA-approved products under physician-guided protocols.